INTRODUCTION
and Norwalk-like viruses (6, 87, 187, 278, 401) , caliciviruses (112, 231) , astroviruses, (229, 230) , and possibly coronaviUntil 15 years ago, the causes of acute nonbacterial ruses (322) . The common enteroviruses are associated with gastroenteritis were unknown. However, during the 1970s, a relatively few cases of viral gastroenteritis (15) . The various number of viruses associated with this clinical syndrome viral agents were discovered by the method of electron were discovered, and their presence in the stools of patients microscopy (EM), using EM to examine stools or intestinal with gastroenteritis were eventually correlated with the biopsies from these patients (18, 33, 110, 253) . As a group, disease process. These various viruses include rotaviruses these viruses are fastidious and cannot be cultivated in
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Rotaviruses are in the Reoviridae family, the members of which possess a double-layer of icosahedral shells of approximately 70 nm in diameter, with a core of double-stranded ribonucleic acid (dsRNA). Rotaviruses infect a wide variety of mammals and birds as well as humans. Most rotaviruses from various species are similar and share a common group antigen, which is associated with the inner capsid layer. However, some rotaviruses do not possess this group antigen. Rotaviruses are responsible for a significant proportion of gastroenteritis in small children and infants, as well as for causing gastroenteritis in the elderly. Similarly, animal and avian rotaviruses are responsible for gastroenteritis in the young of their corresponding species.
Molecular Biology and Classification
Rotaviruses contain a dsRNA genome consisting of 11 segments, ranging in molecular weight from 0.4 x 106 to 2.0 x 106 (275) . These 11 segments can be separated by polyacrylamide gel electrophoresis (PAGE) (103, 182) , using the method of Laemmli (212) . Different rotavirus isolates frequently exhibit differences in the electrophoretic mobilities of their 11 segments. Rotaviruses exhibiting these different electrophoretic mobilities have been termed electropherotypes. Although frequently many of the rotaviruses isolated in the same geographical location at the same time of year may exhibit similar or identical electrophoretic mobilities, there has been considerable variation in electrophoretic mobilities of viruses isolated during different seasons or at different locales during the same season. For example, Rodger et al. (304) described 19 1981 . Attempts have been made to characterize and classify human rotaviruses based on their electrophoretic mobilities. However, the variation has been too great, except for two patterns of electrophoretic mobility that have been distinguished (103, 182) . These are the "short" pattern and the "long" pattern, in which gene segments 10 and 11 migrate more slowly, creating a short pattern, or more rapidly, creating a long pattern, in the polyacrylamide gels (103, 182) . To study the problem of genetic relatedness among various electropherotypes, Flores et al. (115) prepared singlestranded RNA probes for hybridization to gene segments which consist of dsRNA. They found that corresponding gene segments that exhibited similar migration patterns did not necessarily exhibit RNA homology when studied by hybridization with the probes. Conversely, some corresponding gene segments that exhibited RNA homology with the probes did not have the same electrophoretic migration pattern. Thus, they concluded that similarities or differences in electrophoretic mobility did not always reflect similarities or differences in genetic relatedness between various RNA segments (115) . However, it has been shown that electropherotypes are excellent markers for identifying and following the spread of viruses from one individual to another in discrete outbreaks; thus, they are good for providing epidemiological information (47, 304) .
In addition to segments 10 and 11, three gene segments are of particular interest since they code for three major rotaviral antigens, VP4, VP6, and VP7. The major antigens of rotavirus and the genes that code for them are shown in Table 1 . Gene segment 4 codes for VP4 (179, 219, 222, 243, 335) . Originally the product of gene 4 was called VP3, but Liu et al. (219) recently proposed that the gene 4 product be called VP4 while the product of gene 3 be called VP3. Gene segment 6 codes for VP6 (180) . Depending on the strain of rotavirus, gene segment 8 or 9 codes for VP7 (25, 180) . For example, gene segment 8 codes for VP7 in the human serotype 2 rotavirus Hu/5 isolated in Melbourne, Australia (95) , and for the bovine rotavirus UK (207) . Gene segment 9 codes for VP7 in the human serotype 1 rotavirus Wa and for the simian rotavirus SA11 (180, 183, 207) . VP4 is an outer capsid protein which has an apparent molecular weight of 88,000 (241) . VP4 is associated with two biological functions involved with virus-cell interaction: hemagglutination and protease-enhanced plaque formation (179, 222, 241, 335) . VP4 is also responsible for the restriction of growth in cell culture (114, 180) .
VP6 is the major inner core structural protein which is present in large amounts in the virion. It has an apparent molecular weight of 42,000 (25, 93, 94, 240, 275) . VP6 is the major subgroup antigen which can specify one of two rotavirus subgroups (subgroups I and II) (25, 180) . These subgroups have been differentiated on the basis of a variety of tests. These include differentiation by electrophoretic migration patterns of gene segments 10 and 11 in PAGE 418, 421), using either polyclonal sera or monoclonal antibodies (132, 355) . However, some monoclonal antibodies react with viruses in both subgroups, so VP6 proteins must also share common epitopes. VP7 is the major outer capsid protein which is glycosylated and has an approximate molecular weight of 34,000 to 40 ,000 (93, 106, 163, 180, 183, 207, 275, 335, 350) . This protein is responsible for the serotype specificity of the virus (10, 92, 94, 95, 106, 163, 180, 337) , which was initially determined by virus neutralization (166, 402, 404) . Although VP7 is the major determinant of neutralization, VP4 can also elicit neutralizing antibody (10, 135, 165, 272, 335) . At least four human serotypes have been identified: serotypes 1, 2, 3, and 4 (106, 163, 404) . Subgroup I includes human rotavirus strains of serotype 2, which is represented by prototype strain DS-1 (106, 357, 402, 404) . Subgroup II includes serotype 1 (represented by prototype strain Wa) and serotypes 3 and 4 (106, 165, 357, 371, 402, 404) .
Although at least four human serotypes have been identified (106, 163) , a possible fifth serotype from Indonesia has been described by Matsumo et al. (242) . This virus strain, strain 69M, has a "super-short" RNA electrophoretic pattern of gene segments 10 and 11. By RNA-RNA hybridization, 69M was found to have a low degree of homology with the representative strains of all four known human serotypes, and it could not be classified by neutralization analysis into any of these four serotypes (242) . Albert et al. (4) also detected two similar super-short strains designated B37 and B38 in Indonesia.
A sixth possible serotype, strain W161 isolated in the United States, has been described by Clark et al. (61) . By cross-neutralization tests, this virus was distinguished from human rotavirus serotypes 1, 2, 3, and 4, from human strain 69M, and from bovine (NCDV), porcine (OSU), and chicken (Ch2) rotaviruses (61) .
Until recently it was thought that all human and animal strains of rotavirus possessed a common group antigen (399) . However, various rotaviruses have been isolated from humans and animals that do not possess that common group antigen originally reported by Flewett and Woode (113, 399) . Rotavirus strains lacking the common group antigen have been isolated from humans, cows, lambs, pigs, rats, and birds (34, 73, 81, 105, 124, 270, 305) . These more newly discovered viruses are morphologically indistinguishable from other rotaviruses in that they consist of a doubleshelled icosahedran containing 11 genome segments of dsRNA; however, they have an electrophoretic pattern that differs from that of known rotaviruses. These agents have been called "rotavirus like," (170, 305) "antigenically distinct rotaviruses," (81, 101) "pararotaviruses," (24, 105, 270) "atypical" rotaviruses (285, 286) , and "novel" rotaviruses (171) . More recently, Pedley et al. (285) , studying atypical porcine rotaviruses, introduced the designation group A, B, C, etc., analogous to influenza virus terminology. They proposed the usage of group A for the original conventional rotaviruses with the common group antigen and groups B and C for more recently discovered atypical rotaviruses that (i) possess other group antigens and (ii) are genetically different based on (a) electrophoresis of the 11 gene segments and (b) one-dimensional terminal fingerprinting analysis of the RNA segments. Later, Pedley et al. (286) , after analyzing atypical porcine and chicken rotaviruses, described group D and E rotaviruses.
Human rotaviruses belonging to groups B and C have now been described. Atypical strains were analyzed by antigenic analysis (IEM, immunofluorescent-antibody assay, and/or EIA) and by genome profile analysis, terminal fingerprint analysis of genome segments, and/or dot blot hybridization (34) . Sporadic single observations of group C rotaviruses in humans have been made in a few laboratories (34) . For example, analysis of two atypical rotaviruses from Australia and Brazil were found to be in group C (34). Eiden et al. (101) , found that five of six human isolates from the United States were related to porcine and bovine group B rotaviruses. In China, group B rotaviruses have been found to cause severe epidemics of diarrheal disease (48, 170, 171 ). An unusual characteristic of the outbreaks in China was that a much higher attack rate was noted among adults than among children. However, Dai et al. (73) described an outbreak of diarrhea among newborns caused by the new Chinese rotavirus that was placed in group B by Chen et al. (48) . This is probably the first report of neonatal infection caused by group B virus since group A rotaviruses have been the primary cause of outbreaks in neonatal nurseries in a number of countries. To summarize, rotaviruses can be classified by four main categories: group specificity, serotype specificity, subgroup specificity, and strain specificity. mucosal epithelial cells obtained by duodenal biopsy of a group of Australian children hospitalized with nonbacterial gastroenteritis. In the same month, Flewett et al. (109) described similar reoviruslike particles seen by EM in stool specimens from patients with gastroenteritis in the United Kingdom. Shortly thereafter, the finding of these viruses in patients, but not controls, was reported from Singapore (354) , Canada (252) , southern Africa (65), India (164) , the United States (186) , and Scandinavia (277). Flewett et al. (111) suggested the name "rotavirus" based on the wheellike appearance (Fig. 1A ) of these viruses.
The seriousness of rotavirus infection was exemplified by the reports of Middleton et al. of seven fatal cases occurring out of 60 rotavirus-infected patients (252) and a review of 21 fatal cases (41) . Others reported that this virus was also responsible for nosocomial outbreaks of gastroenteritis in nurseries (40, 56, 261) . Chrystie et al. (56) also noted that in neonates the disease was mild or symptoms were lacking entirely. In addition, young adults, i.e., parents of rotavirusinfected infants, infrequently excreted large amounts of virus and infrequently developed symptoms or had only mild symptoms (56, 185, 261, 307) . Often the only evidence of infection in parents was determined by fourfold or greater rises in serum antibody titers (185) .
Rotaviruses are responsible for approximately 50% or more of the gastroenteritis in hospitalized pediatric patients during the cooler months of the year in parts of the world that have temperate climates (15, 76, 152, 185, 203) . These worldwide reports of the high incidence of rotavirus infection have come from urban populations. However, the incidence of rotavirus infection appears to be somewhat lower or absent in patients from rural areas as reported from Australia and South Africa (89, (321) (322) (323) . There may be several reasons for this. One is that rotaviral colonization of neonates may lead to protection against symptomatic infection later in infancy. Another reason may be that, in some instances, a lack of overcrowding may prevent the virus from spreading easily. Also, differences in diet or lifestyle in certain rural areas may contribute to a different viral gut flora.
Since many reports indicate that rotavirus infection increases during the cooler months, the role of weather in altering the rotavirus infection rate has been studied in various parts of the world by a number of investigators. In temperate climates such as in northern Japan, increases in the infection rate appeared to be related to the drop in temperature, but not to the outside relative humidity (205) . In Washington, D.C., rotavirus gastroenteritis increased CLIN (28) . Brandt et al. (28) suggested that indoor crowding and low indoor relative humidity may increase aerosolization of rotavirus particles on surfaces, as well as contribute to dehydration of infected infants during these months. However, in another report, rotavirus prevalence in southern California during one season (October to December) did not correlate with either the coldest or the driest months of the year. In some tropical countries, including Nigeria (282) , southern India (235) , Bangladesh (20) , Indonesia (336) , Ecuador (348) , and Costa Rica (152) , rotavirus infections tend to peak during the dry season. However, no distinct seasonal variation occurred in other reports from tropical countries, including Ecuador (345) and Venezuela (80) (191) . Many day-care children are asymptomatic, indicating a large reservoir of infection. The numbers of infected children range from 10 to 30%, depending on the study (9, 191) . In one study (9) 20% of the adults directly involved in child care were infected, although they were primarily asymptomatic.
However, adults have also experienced more severe clinically acute cases of rotavirus gastroenteritis. von Bonsdorff et al. (385) Although group A rotaviruses have been responsible for almost all of the rotavirus infections in both the young and the elderly in North America and Europe, a new group of rotaviruses has been responsible for large outbreaks of severe rotavirus diarrhea occurring in adults of all ages in China (171) . These rotaviruses did not share the group antigen (group A) of known rotaviruses at the time and were found to belong to a new group, group B (48). Human infection with group B rotavirus has not been widespread outside of China, however (267, 368) .
Within the group B rotaviruses, subgroups and types have not been delineated as has been done with the group A rotavirus. Within the A group of rotaviruses, the prevalence of the subgroup and the type of rotavirus causing infection have been studied. White et al. (394) subgrouped 99% of 252 specimens obtained from Venezuelan children over a 45-month period. Some 14% shed subgroup I and 85% shed subgroup II rotavirus. Of the subgroup I viruses, one-half were shed during a 3-month period. There was no difference in the occurrence of fever and vomiting between the children with either subgroup, but patients with subgroup II infections had longer-lasting illness.
Yolken et al. (418) studied 414 rotaviruses isolated from patients in Washington, D.C., Belgium, and Central America. They found that 23% were type 2 (subgroup I) and 77% were type 1 (subgroup II), with a similar distribution from various parts of the world. In an analysis of children who were reinfected, sequential infections usually involved different serotypes, and illness caused by one serotype did not provide resistance to illness caused by the other serotype. Studying the prevalence of various subgroups and types is an important consideration for determining which rotavirus type(s) to incorporate into rotavirus vaccines. (161, 367, 381) . The two most prominent features were vomiting and diarrhea, usually with sudden onset. Vomiting appeared to be the most common first symptom, occurring first in 34 to 55% of patients, depending on the study. Vomiting often preceded the onset of diarrhea by a few hours to 24 h and occurred at some time during illness in 48 to 92% of patients, with a mean duration of 3 days. Diarrhea was the first symptom to occur in 23 to 29% of patients, depending on the study. Diarrhea occurred at some time during illness in 65 to 100% of patients and lasted a mean of 5.0 to 5.9 days. Vomiting and diarrhea started simultaneously as the first symptoms in 22% of patients. Characteristically, there was an absence of blood in the stools (161) . Fever occurred first in 13% of patients and occurred at some time during illness in 34 to 86% of patients. Abdominal pain was somewhat infrequent, occurring in 17 to 29% of patients. Respiratory symptoms occurred first in 24% of patients and occurred at some time during the illness in 24 to 52% of patients. Overall, symptoms were more severe in hospitalized patients than in patients not requiring hospitalization, and patients in poorer general condition were more dehydrated.
There have been conflicting reports on the role of rotavirus in causing respiratory infection and symptoms. Lewis et al. (216) reported respiratory illness in 66% of rotavirus gastroenteritis patients versus 26 to 38% of nonrotavirus gastroenteritis patients. Respiratory symptoms usually preceded gastrointestinal symptoms, although they also occurred concurrently, and consisted of rhinitis, pharyngitis, tonsillitis, and otitis media.
Yolken and Murphy (413) identified rotavirus by EIA in tracheal aspirates from two of five infants who died of sudden infant death syndrome who had acute upper respiratory infection. Although none of these infants had gastroenteritis, rotavirus was also detected in their stools. Similarly, Santosham et al. (317) detected rotavirus in respiratory secretions from 4 of 45 pediatric patients with pneumonia. None of the four had diarrhea. However, since they had prior antibiotic treatment, and Mycoplasma sp. was also found in one child, bacteria may have been the cause of the pneumonia. Fragoso et al. (118) also detected rotavirus antigen in respiratory secretions in 2 of 30 children with both upper respiratory tract infection and vomiting.
To study the role of rotavirus in respiratory infection, Prince et al. (291) used a murine rotavirus model to demonstrate that aerosol transmission can occur. The result was both respiratory and gastrointestinal infection and gastroenteritis. The authors concluded that, since rotavirus may be found in respiratory secretions of children, it may be transmitted by the respiratory route as well as the fecal-oral route.
However, several groups have failed to show any significant role of rotaviruses in respiratory infection. Goldwater et al. (127) , using direct EM, IEM, and EIA, failed to detect rotavirus in respiratory secretions of rotavirus-infected patients. Their study included specimens obtained from patients with respiratory symptoms prior to the onset of gastroenteritis. Similarly, Vollet et al. (384) could not detect rotavirus in 11 of 13 children with rotavirus diarrhea who also had respiratory symptoms.
Maki (236) found no difference in respiratory symptoms in rotavirus gastroenteritis patients (53%) or nonrotavirus gastroenteritis patients (62%). Hjelt et al. (161) found no more upper respiratory tract symptoms in rotavirus gastroenteritis patients (36%) than in nonrotavirus gastroenteritis patients (35%). Similarly, Uhnoo et al. (367) observed respiratory symptoms in 32% of rotavirus gastroenteritis patients, but these data were not significant when compared with respiratory symptoms in patients with gastroenteritis caused by other viruses or bacteria or when no agent was detected.
These data suggest that rotaviruses may sometimes cause respiratory symptoms. Differences seen in the various reports may depend on the locale, the year, and the strains of rotaviruses involved. Some patients with nonrotavirus gastroenteritis and respiratory symptoms had infection caused by adenoviruses, which are known to cause both gastrointestinal and respiratory symptoms simultaneously (see below). Thus, the respiratory symptoms occurring in the adenovirus gastroenteritis groups may have contributed to the lack of significance observed between the rotavirus and nonrotavirus gastroenteritis groups in some of the reports.
Various other complications have been reported to occur with rotavirus infection. Fernbach and Lloyd-Still (107) reported three patients with severe, prolonged rotavirus colitis with bloody stools. Wong et al. (397) reported a case of aseptic meningitis associated with rotavirus gastroenteritis in which rotavirus particles were seen in the cerebral spinal fluid by IEM. Ushijima et al. (373) reported on a case of encephalitis that developed during rotavirus gastroenteritis, in which rotavirus immunoglobulin G (IgG) increased in the patient's cerebrospinal fluid. In addition, rotavirus-like particles have been detected by EM and EIA in a liver biopsy in a case of hepatic abscess (139) .
Pathogenesis. Rotavirus infection is spread primarily by the fecal-oral route. Although rotavirus is relatively acid labile, rotavirus can survive the pH of a stomach that is buffered, or can survive in the stomach after a meal. At pH 2.0 (that of a fasting stomach), rotavirus is rapidly inactivated in <1 min (393) . However, at pH 3.0, inactivation is much slower, the viral half-life being about 10 min; at pH 4.0, inactivation is minimal. The infant gastric pH tends to be approximately 3.2, and in general, the stomach pH remains above 3 .0 for at least 1 h after a meal. This probably explains the efficient transmission of rotavirus.
To determine the infective dose required to produce infection with or without symptoms, adult volunteers ingested 0.009 to 90,000 focus-forming units of rotavirus (390) . Results showed that as little as 0.9 focus-forming unit caused infection in one of nine volunteers, as determined by viral shedding and a significant rise in antibody titer. A 9-focusforming unit dosage caused infection in 8 of 11 volunteers, with 6 of these having symptoms. Higher viral doses caused higher percentages of infection, but no increase in the number of individuals with symptoms.
Rotaviruses tend to infect the small intestine, as do other gastroenteritis viruses. In particular, rotavirus replication takes place in epithelial cells on the tips of villi of the small intestine, and infection is confined primarily to these cells (405) . Rotaviruses selectively infect the mature villus enterocytes of the small intestine; rotaviruses exhibit a predilection for young animals of many animal species (273) .
The histology of duodenal biopsies obtained from rotavirus gastroenteritis patients was first described by Bishop et al. (18) . A patchy irregularity of the mucosal surface was seen in most cases. Mucosal changes ranged from mild to severe. The changes included shortening and blunting of villi and increased infiltration of the lamina propria with mononuclear cells. Epithelial cells were more cuboidal and less Davidson and Barnes (74) found mucosal damage to be quite variable and often patchy. Mild changes in seven of their patients included broadening of villi, mild cellular infiltration of the lamina propria, and early epithelial cell damage. Moderate changes in eight patients involved considerable blunting of villi, obvious increase in inflammatory cells in the lamina propria, increased crypt depth, and flattening of epithelial cells. Severe changes in two patients showed complete villous flattening, marked inflammatory cell infiltration, crypt hypertrophy, and severe epithelial damage with cuboidal epithelium. The severe damage could be confused with the structural appearance seen in coeliac disease. Rotavirus particles were observed by EM in the cytoplasm of infected cells. Mucosal damage was rapidly repaired, as early as 3 weeks after onset. They found that children with a more severe mucosal lesion were more likely to become dehydrated and require intravenous therapy for rehydration.
In bacterial gastroenteritis, abdominal pain, bloody stools, leukocytosis, and prolonged diarrhea are more likely to occur than in viral gastroenteritis (367) . Viral gastroenteritis also differs from bacterial gastroenteritis in its physiology (360) . In rotavirus infection, there is patchy replacement of infected mature villous tip cells by secretary crypt cells, decreased intracellular Na+,K+-adenosine triphosphatase activity, and impairment of glucose-coupled sodium transport (360) . Abnormally low maltase, sucrase, and lactase levels were also found in children with rotavirus gastroenteritis (18, 74) , which returned to normal after 4 to 8 weeks. Most (but not all) children with acute rotavirus gastroenteritis have lactose malabsorption and intolerance (172) . An increase in diarrhea can occur after feeding lactose, so that a non-lactose-containing formula is usually given during rotavirus illness when infants are able to take fluids orally. Normal lactose tolerance reappears by at least 10 to 14 days after the start of illness, when lactose-containing products can then be introduced (172) .
Loss of fluids and electrolytes in rotavirus gastroenteritis can lead to severe dehydration and even death and requires fluid and electrolyte replacement therapy. In developing countries, recurrent bouts of gastroenteritis can lead to a vicious cycle of protracted diarrhea, food intolerance, and malnutrition (360) . The malnutrition may be further compounded by frequent fasting, which is a measure commonly used in the management of acute gastroenteritis in some developing countries (360) . For marginally nourished or malnourished children, diarrhea with associated starving can have deleterious effects. When a person has fasted for 3 to 5 days, depletion of intestinal digestive enzymes and gut mass occurs and absorption of water, salt, glucose, disaccharides, and amino acids are substantially reduced (360) .
In spite of these multiple physiological abnormalities, oral replacement therapy is effective in correcting dehydration in rotavirus gastroenteritis. Its effectiveness is probably due to the presence of intact glucose-coupled sodium transport in noninfected bowel (360 (268) . Since children usually have had several episodes of diarrhea before their parents seek medical attention, usually no bacteria are remaining in their stools by the time a sample is submitted to the laboratory. However, some laboratories prefer to clarify stool suspensions (20%) by low-speed centrifugation. In some instances the clarified supernatant is subjected to ultracentrifugation to pellet and concentrate any virus particles present. The resuspended pellet is then used for preparing grids, followed by negative staining.
In IEM, patients' convalescent sera are mixed with a virus suspension. These suspensions can be obtained by purifying virions from stools or from infected cell culture fluids. After incubation of the virus-serum mixture, the mixture is placed on a grid and stained with phosphotungstic acid.
Nicolaieff et al. (269) (13, 63, 162, 287, 349) . This first antibody has been termed the "capture," "coating," "catching," or "primary" antibody. Next the specimen is added, and if virus is present, it will bind to the rotavirus antibody. A second antibody, the "detector" or "secondary" antibody, is then added. In many EIAs, the second, detector antibody is conjugated to an enzyme, making it also an "indicator" antibody. In some EIAs, however, the detector antibody is not conjugated to an enzyme. In these instances, a third, "anti-antibody" or indicator antibody which is enzyme conjugated is added (144, 167, 318, 421 The sensitivity was determined to a great extent by the time after the onset of illness during which the specimens were collected. There was no significant difference in the three tests when they were run on specimens collected early in the patients' illnesses. However, lower degrees of sensitivity were seen with the Rotazyme and Rotalex on specimens obtained later in the patients' illnesses. The lower sensitivity of the Abbott Rotazyme was not statistically significant, although the lowered sensitivity of the Rotalex LA was statistically significant. In addition, these authors found that a 104 50% tissue culture infective dose per 0.1 ml of virus suspension was detected at a 1:300 dilution by Bio-EnzaBead, at a 1:30 dilution by the Abbott Rotazyme, and at a 1:10 dilution by the Rotalex LA. There were no false-positive results with any of the three commercial tests, and this was seen with newborn as well as other specimens.
Pai et al. (280) compared Rotalex (Finland) with Rotazyme I and EM with 165 stools from children and neonates.
Rotalex had a sensitivity of 82% and a specificity of 96% compared with EM and was slightly more sensitive and specific than Rotazyme T. These authors also found that the sensitivity with Rotalex was dependent on the time of collection of stool samples relative to onset of symptoms. Sensitivities of Rotalex were 100, 96, 60, and 33% during 1 to 4, 5 to 7, 8 to 10, and 11 to 18 days, respectively, after onset of symptoms, and similar results were observed with Rotazyme T. Of 214 EM-negative specimens from asymptomatic newborns, the false-positive rates were 3.3% (7 of 214) for Rotalex and 4.2% (9 of 214) for Rotazyme I.
Several (414) initially reported problems with nonspecific reactions in ETAs. The nonspecific activity was markedly reduced by pretreatment of the specimens with reducing agents, normal goat serum, and anti-human IgM. The authors concluded that it was likely that the specimens contained an IgM antibody capable of reacting nonspecifically with other components of the assay. Although pretreatment with the mild reducing agent N-acetylcysteine markedly reduced this nonspecific activity, such treatment did not reduce the specific EIA activity due to rotavirus.
Studies by Hovi et al. (167) suggested that false-negative results might result from fecal protease activity. This problem could be alleviated by adding 1 to 5% bovine serum to dilution buffers or by using a synthetic broad-spectrum serine-type protease inhibitor.
Hogg and Davidson (162) evaluated false-positive results. They found that, when they incorporated preimmunization serum-coated wells as control wells in their EIA, 9.7% of specimens giving positive results were eliminated as falsepositives.
Several investigators have reported problems with falsepositive EIA results on specimens from neonates. These occurred especially in earlier studies with Rotazyme I, in which lower positive cutoff values were used. When the cutoff value was raised, some of the problems appeared to be eliminated.
Krause et al. (208) reported that 22% (79 of 358) of neonatal stool specimens from both asymptomatic and diarrheal neonatal patients were positive by Rotazyme I, although of 61 of 79 positives that were analyzed by confirmatory tests, only 7% (4 of 61) were confirmed as positive. This was compared with 77% that were confirmed Rotazyme-positive specimens from children and adults. Suggested causes of these false-positive Rotazyme tests in neonates included nonspecific binding of rotavirus antibody to bacteria or staphylococcal protein A in neonatal stools.
However, Pai and Mayock (279) , using Rotazyme I to study specimens from infants under the age of 4 months, found that only 9.8% (21 of 214) that were negative by EM were positive by EIA and thus presumed to be falsepositives. However, only 4.5% (9 of 202) were positive when visual readings of >1+ were considered positive, as recommended by the manufacturer. Similar results were seen by Rand et al. (294) , who studied stool specimens from diarrhea-free infants in a neonatal intensive care unit with Rotazyme T. None had rotavirus by EM. By EIA, only 6 .8% (10 of 147) were considered either low-level positive or suspect positive. Excluding the suspect positives, which were negative on repeat testing, the false-positive rate was 4.1% (6 of 147). With five repeatedly positive specimens with sufficient quantity to retest, heating to 560C for 30 min eliminated binding to the Rotazyme bead; heating had no effect on the Rotazyme-positive control. One highly falsepositive result was not changed by heat or other treatment.
Thus, the investigators concluded that heat treatment of positive samples from neonates could eliminate most of the false-positives, although false-positives may result from more than one cause.
Chrystie et al. (58) found a 15% (8 of 53) false-positive rate on specimens from 5-day-old babies, using Rotazyme T. However, they used an initial cutoff value specified in early Rotazyme directions; had a revised, higher cutoff value been used, only 1.9% (1 of 53) of the neonatal samples would have been falsely positive (295, 365) . In addition, weakly positive and borderline Rotazyme reactions correlated poorly with direct EM findings (12, 50, 295 Herrmann et al. (151) compared both Rotazyme and their own EIA, which used a monoclonal detector antibody, with EM. They evaluated specimens from three types of patients: neonates, children, and adults. The sensitivity of their monoclonal EIA was 100% for all, while that of Rotazyme was 100, 86.2, and 50.0% in the three types of patients, respectively. The specificity of the monoclonal EIA was 100, 95.6, and 96.5%, while that of the Rotazyme was 37, 95.6, and 89.7% respectively. Thus, they concluded that, especially for specimens from children and adults, greater sensitivity and specificity could be achieved with monoclonal antibody as detector antibody as compared with Rotazyme. Also, use of the monoclonal antibodies eliminated the false-positive reactions seen in specimens from neonates when Rotazyme was used. Herrmann et al. thought that, by using monoclonal antibodies as detector antibodies, the test sensitivity may be decreased, since these antibodies react with only one epitope of a given antigen. This problem could be diminished by using monoclonal antibody as a capture antibody and a polyclonal serum as the detector antibody, as these investigators had reported for a rotavirus RIA. The advantage of using the monoclonal antibody for capture is that it may pick up a significant amount of an antigen with several different epitopes. These investigators considered that the polyclonal sera may contain a number of cross-reacting components and may be the cause of false-positives in neonates, since false-positives occur in neonatal specimens in other rotavirus ETAs besides Rotazyme. The disadvantage of using polyclonal antibodies as a detector is that they may react nonspecifically with antigen adsorbed to the solid phase. This may occur even if inhibitors such as serum, serum fractions, or gelatin are included in the diluents to block nonspecific reactions. For example, they found that in stools containing high titers of rotavirus there was sufficient reactivity to give a positive test with microtiter plates coated with preimmune sera, even though there was two to three times greater reactivity with plates coated with immune sera. None of the studies to date has found false-negative Rotazyme results in neonates.
Other detection methods. Other testing procedures were also developed to detect rotaviruses or rotaviral antigens. Some of the earlier tests included counterimmunoelectrophoresis (237, 250, 251, 339, 366) , CF (420, 422) , various immunofluorescence tests (39, 358, 415) , and RIAs (181, 249) . Counterimmunoelectrophoresis and the CF test are rarely used now, since they are relatively insensitive. The RIA is sensitive (14, 319) and suitable for the study of large numbers of specimens, but the need for radioactive reagents and expensive radiation-counting equipment makes it impractical in many situations.
Other techniques for detecting rotaviruses in stool samples have been developed. They are primarily research techniques and are not used routinely. Among the in vitro tests are an immune adherence hemagglutination test (262) , a reverse passive hemagglutination test (314, 315) , and a solid-phase aggregation of coupled erythrocytes technique (26, 388) , and PAGE (258) . Various methods to detect rotavirus or rotavii-al proteins in infected cell cultures have been developed and include a collodial gold-protein A-IgG technique (289), a radioimmunofocus assay (220) , and an immunoperoxidase procedure (44) . More recently, several sensitive and specific research techniques for the detection of rotavirus in clinical specimens have been developed, which include a dot-immunobinding assay (299) , a dotavidin-biotin-amplified immunobinding assay (299) , an avidin-biotin RIA (407) , and several dot hybridization techniques (82, 100, 116, 217 (155, 159) found that the immunoglobulin secretory component (ScIg) increased in serum 1 to 2 weeks after disease onset; however, it had disappeared by 4 months. Grauballe et al. (129) detected sIgA in patient sera for only 4 to 10 days after rotavirus was detected in stools, and this correlated well with recent infection. These differences may have been due to differences in the sensitivities of the EIA tests used. Hjelt et al. (155, 159) found that the amount of ScIg in the serum after 1 week correlated with the amount found in the duodenal fluid. Rotavirus IgA in feces still persisted in most patients at 6 months postinfection, whereas ScIg had disappeared in the feces of all patients except one.
The intestinal antibody response has been studied by other investigators as well (Table 3) . In fecal specimens, Riepenhoff-Talty et al. (301) found rotavirus-specific sIgA in both acute and convalescent samples. Davidson et al. (75) reported that IgA in duodenal secretions was significantly higher in convalescent-phase secretions than in acute-phase specimens, although duodenal IgM levels were the reverse. In patients with severe or prolonged infection, convalescent duodenal sIgA levels were higher than in patients with mild or moderate disease (301).
Sonza and Holmes (338) studied fecal antibodies in four small children after a family outbreak. Although low levels of fecal IgG, IgM, and IgA were observed in most cases at the time of onset, the levels started increasing by 1 to 2 weeks, peaked by 3 to 5 weeks, and quickly declined so that none were detectable after 2 months.
Stals et al. (344) found that maximum excretion of fecal IgA occurred about day 7 of illness, when virus excretion, which peaked at 2 to 5 days, was subsiding. They concluded that IgA limits the duration of diarrhea and plays a major role in intestinal resistance to infection. Shinozaki et al. (331) detected fecal IgA at day 9 postinfection in their patients; excretion of rotavirus had subsided by day 8 in these patients. Fecal IgA reached a maximum titer by 2 to 6 weeks and then declined. Yamaguchi et al. (406) found that in primary infection fecal IgA appeared at 1 week after the onset of illness, and titers reached a plateau between 3 and 5 weeks and then declined gradually. In reinfection, IgA titers increased more rapidly and were maintained at higher levels for a longer duration, typical of an anamnestic response. To determine whether IgA appearing after primary infection limits the infection and plays a role in resistance to reinfection, challenge studies would probably have to be carried out in volunteers or prospective studies would have to be done.
Thus, in a prospective study, Hjelt et al. (158) Peak levels lasted longer detected sooner normal mothers and in cord blood and stools of their were low. In bottle-fed infants, no specific IgA was found in newborn infants (Table 4 ). These studies have been imporfecal supernatant fluids. tant because of the possible role of immunoglobulins in the Hjelt et al. (157) found that the levels of IgA and ScIg in protection of infants from rotavirus infection. milk declined from 3 to 4 days postpartum to 2 weeks later McLean and Holmes (245) studied 92 mother-infant pairs.
and then remained unchanged for 2 months. In duodenal Rotavirus-specific IgG, but not IgM, was detected in all fluid, rotavirus IgA and ScIg were seen only in a minority of maternal and cord sera tested, and this was the only immuinfants at 3 to 4 days and 2 weeks after birth. However, 80% noglobulin that crossed the placenta. Rotavirus-specific IgA of fecal samples contained rotavirus-specific IgA and ScIg, was found in 100% of maternal sera tested, while specific although they disappeared after lactation ceased. InterestScIg was found in 53% of the maternal sera. In another ingly, IgA and ScIg can survive proteolysis in the gut. Thus, study, Hjelt et al. (157) found that all of the mothers tested frequent breast meals have a possible protective effect. had IgG and IgA in their sera and 78% had low levels of ScIg Yolken et al. (412) studied secretary antibody (ScIg) to in their sera 3 to 4 days postpartum. Infant serum IgG levels rotavirus in human colostrum and milk. They found rotacorrelated well with those of their mothers, but they had no virus-specific ScIg in all colostral samples and most of the rotavirus IgA or ScIg in their sera. milk samples. Peak ScIg levels in colostrum fell to low but These same two groups of investigators also evaluated the detectable levels in milk 1 to 2 weeks postpartum and protective role of immunoglobulins in the colostrum and remained at these levels for 2 years after delivery, similar to milk in the same two groups of normal mothers. Rotavirusresults reported above. There were no significant differences specific IgG and IgM were found in the colostrum and milk in samples from different geographical areas of the world. of many of the mothers by McLean and Holmes (245) , and Cukor et al. (71) studied rotavirus-specific sIgA in moththese levels dropped off significantly by 3 to 5 days postparers' milk. They found that 80% of the mothers were positive tum. Rotavirus-specific IgA and ScIg were found in all for IgA <1 week after parturition, 50% were positive 7 to 14 colostrum and milk samples, except for two mothers who days postpartum, and 24% were positive at 1 month postwere IgA deficient. Specific IgA and ScIg levels in colospartum. However, as late as 6 to 9 months postpartum, 56% trum-milk dropped off rapidly immediately postpartum to a of those tested were positive. This was due to mothers who steady low level at 3 to 4 days postpartum. In breast-fed were initially negative eventually becoming antibody posiinfants, specific IgA was found in fecal supernatant fluids tive, possibly because of a subclinical rotaviral infection. after 2 days, even when maternal milk IgA concentrations Thus, two routes of passively transferred rotavirus antibody (118) . In addition to specific antibodies, nonspecific factors in milk and in the gut may play a role in the protection of infants against rotavirus infection. Studies by McLean and Holmes (247) suggested that both sIgA and trypsin inhibitors in human milk may protect neonates against rotavirus infection during the first 5 days of life. They found that breast-fed babies were less likely to become infected with rotavirus and showed lower stool tryptic activity or higher antirotaviral sIgA antibody, or both, than bottle-fed babies.
While the above studies concentrated on the levels of various rotavirus-specific immunoglobulins in body fluids, these levels were not correlated with their possible role in the protection against, or modification of, rotavirus infection and disease.
Thus, several studies have been done on the role of specific rotaviral antibody in rotavirus infection. Chrystie et al. (57) studied rotavirus infection in an endemic situation in a neonatal nursery. They found that breast-fed babies excreted rotavirus significantly less frequently than those who were formula fed. Also, if infection did occur among breastfed infants, they excreted less virus than infected formulafed infants. More specifically, in a second publication, this group (363) reported on the role of specific antibody in cord blood and breast milk in this same outbreak of rotavirus gastroenteritis. The ranges, distributions, and geometric mean titers of serotype 2-specific IgG in cord blood and serotype 2-specific IgG and IgA (97% positive) in the mothers' breast milk were similar among rotavirus-positive and rotavirus-negative neonates. Interestingly, there was no correlation between the amount of milk IgA antibody and the amount of neonatal viral excretion. These studies suggest that factors other than rotavirus antibody in breast milk are of importance in preventing rotavirus infection in neonates.
To determine which nonspecific factors may play a role in resistance to rotavirus infection, these same workers (364) evaluated the role of neutralizing activity, nonimmunoglobulin antiviral activity, and a1-antitrypsin activity in the mothers' milk. They were unable to correlate any of these factors with protection from rotavirus infection. However, they found that rotavirus in infected stools from breast-fed infants was frequently clumped, although that in stools from formula-fed infants was rarely clumped (361) . Thus, when they specifically studied human lacteal rotavirus antibodies by IEM (361), they found that the IgA-and IgG-containing fractions in human and bovine milk samples caused aggregation of rotavirus particles. Clumping did not occur with antibody-negative milk or with the nonimmunoglobulin fractions of antibody-positive milk. They suggested that adsorption to susceptible cells of viral aggregates formed in the presence of low levels of antibody and containing unneutralized virus was one mechanism by which infection in the presence of antibody might occur.
Similar results were found by Weinberg et al. (392) . In 50 infants who had rotavirus gastroenteritis within the first year of life, 64% had been breast-fed and 70% had not. There were no significant differences between the two groups in the average age of infection, the mean duration of diarrhea, the mean number of bowel movements in 24 h, or the frequency of fever or irritability. The only apparent difference between the groups was that the frequency of vomiting was significantly decreased in the breast-fed children. Their results suggested that breast-feeding offered little protection against rotavirus gastroenteritis. Similarly, Duffy et al. (90) found that, although rotavirus attack rates were similar between breast-and bottle-fed infants, rotavirus infection in breastfed infants was milder and of shorter duration than in bottle-fed babies.
In addition to studies on the role of passively acquired maternal antibody in neonatal infection, studies on the role of actively acquired antibody in preventing or modifying recurrent infection have been carried out. Bishop et al. (17) studied the ability of neonatal rotavirus infection to confer immunity to postneonatal rotavirus infection. Fifty-five percent of infants with neonatal infection and 54% of those without infection developed rotavirus infection during the following 3 years. Babies with reinfection had symptoms that were significantly less severe than those who had no previous neonatal infection. They concluded that neonatal rotavirus infection does not confer immunity against reinfection, but does protect against the development of clinically severe disease during reinfection.
In addition to the study of natural passive immunity, studies on the use of artificial passive immunity for prevention and treatment of rotavirus infection have been carried out. Barnes et al. (8) evaluated the use of human gamma globulin or placebo given in each feed during the first week of life to 75 low-birth-weight infants in a nursery where rotavirus was endemic. Twenty-five of the babies excreted rotavirus during the first 2 weeks of life and were considered the "challenge" group. Gamma globulin administration was associated with delayed excretion of rotavirus and with milder symptoms. The diarrhea necessitated low-lactose feeds in 55% (6 of 11) of placebo babies but in only 7% (1 of 14) gamma globulin-treated babies. The authors concluded that oral human gamma globulin seemed to protect lowbirth-weight infants from rotaviral diarrhea.
In another study (223) In a larger group of 178 pediatric patients aged 8 to 11 months given the vaccine during the rotavirus season, the protective effect of the vaccine was evaluated (379) . Of the seronegative infants, 47% of the vaccine recipients seroconverted, but there was an 88% protection rate from clinically significant rotavirus diarrhea. In this study, although it appeared that serum antibody could be used as a marker of successful vaccination, protection against clinical diarrhea could not be strongly associated with these serum antibodies. Vaccination and subsequent naturally acquired immunity protected against clinical diarrhea. However, vaccination did not protect against subclinical infection, as determined by a booster response or by antibody seroconversion.
In a pre-rotavirus season vaccination study carried out in the autumn, infants aged 6 to 12 months were given either two doses of the RIT 4237 vaccine or a placebo (377) . Results similar to those of the previous study were seen. Vaccinees who failed to seroconvert had less rotavirus diarrhea than placebo recipients, suggesting that immunity may be mediated by factors other than serum EIA antibody.
The protection rates against clinically significant diarrhea caused by serotypes 1, 2, and 3 were 72, 100, and 100%, respectively.
The RIT 4237 vaccine appeared to protect against several human rotavirus serotypes. In one study, the subgroup I RIT vaccine offered protection during an outbreak of subgroup II rotavirus (379) , which is the most prevalent subgroup seen in the United States. In another study, limited evidence suggested that the RIT vaccine offered protection against serotypes 1, 2, and 3 (377) . Preliminary data also indicated that this vaccine may offer protection for at least 2 years (376).
Since the RIT 4237 strain is relatively acid labile and may lose infectivity if exposed to high gastric acidity occurring between feedings in infants, the investigators felt that an appropriate acid-neutralizing substance such as milk might increase the seroconversion rate. Thus, a RIT 4237 vaccine with 108 3 50% tissue culture infective doses was given to breast-fed, formula-fed, and fasting infants (382) . A neutralizing antibody response occurred in 69% of the breast-fed, 100% of the formula-fed, and 63% of the fasting infants, with an overall response rate of 77%. The breast milk was somewhat inhibitory, since it may give partial protection against naturally occurring rotavirus diarrhea. Poorer responses occurred when the vaccine was used containing Another candidate rotavirus vaccine has been developed and evaluated at the National Institutes of Health (5, 55, 184, 224) . The vaccine strain is also an animal virus, rhesus rotavirus-1 strain MMU-18006. The virus was derived from the stool of a 3-month-old rhesus monkey with diarrhea. It was passed nine times in primary or secondary monkey kidney cell cultures and seven times in a semicontinuous fetal rhesus monkey diploid lung cell strain, DBS-FRhL-2, developed by the Division of Biologic Standards (184) . The major neutralizing protein is closely related or identical to VP7, the major outer capsid protein detected by crossneutralization (380) of human serotype 3 (184, 224) . This vaccine is more immunogenic than the RIT 4237 vaccine, but it also produces more side reactions.
In initial studies, the MMU-18006 strain was found to be attenuated in newborn and juvenile rhesus monkeys. It was first evaluated in human young adults and then children aged 2 to 12 years and was found to be immunogenic in >80%, but caused no side reactions (224) . The vaccine, containing 105 PFU per dose, was then tested in 14 infants aged 5 to 20 months; 13 infants were given placebo. It was administered after the infants received formula buffered with sodium bicarbonate. There was a fourfold or greater rise in serum antibody titer in all of the vaccinees, but none in the placebo controls. The primary side reaction to the vaccine was the development of fever above 100.60F (37.80C) 3 to 4 days postvaccination. All vaccinated children excreted rotavirus in their stools within 1 week of vaccination.
In a similar study of 13 vaccinated infants and 10 controls, significant rises in serum antibody titers occurred in all vaccine recipients, although they also exhibited side effects to the vaccine (5). These included rhinorrhea, passage of a larger than usual number of stools, and passage of more semiformed or unformed stools as compared with controls. All vaccinees shed rotavirus in their stools.
The MMU-18006 vaccine appeared to be more immunogenic but caused more side reactions in American populations than the RIT 4237 vaccine did in Finnish recipients. One difference between the two populations was that, in the Finnish studies, most of the vaccine recipients were initially seronegative as determined by EIA, and many of the remaining vaccinees had only low levels of detectable antibody, whereas higher percentages of the American study group populations had detectable rotavirus antibody prior to vaccination. Since the vaccine populations differed, a collaborative study was carried out comparing the two vaccines in one study population in Finland (380) . Results of both vaccines were similar, with the RIT vaccine being less immunogenic but showing fewer side reactions, while the MMU vaccine was more immunogenic with more adverse side effects.
Adverse reaction rates to the MMU-18006 vaccine were lower, however, in a Venezuelan study. This was due perhaps to differences in preexisting immunity due to maternally transferred antibody in the vaccinees in that country. Thus, the MMU-18006 vaccine might be suitable for this type of population (380) . The MMU vaccine might also be useful in developing countries, when the only chance to vaccinate might be simultaneously with the oral polio vaccine, which might interfere to some extent with the rotavirus vaccine. The MMU vaccine might also be effective in early infancy, when passively acquired antibodies are at a high level and when less side reactions may occur. In such a population, a more attenuated vaccine may not take, as was shown to be a problem with the RIT 4237 vaccine (380 (90, 206) . Thus, the primary purpose of therapy is to correct these problems by providing adequate hydration to maintain blood volume, electrolyte homeostasis, and acid-base balance (90) . Replacement of water and electrolytes in dehydrated patients can be done with either intravenous therapy or oral electrolyte solutions, depending on the clinical situation.
A child with diarrhea must first be assessed for his/her degree of dehydration. This includes evidence of weight loss, changes in skin turgor, sunken eyes, dry mucous membranes, absence of tears, decreased urine output, and changes in mental status or vital signs or both (90) .
Intravenous fluid therapy for significant dehydration and fasting have been the standard therapy in developed nations for over 40 years (90, 218) . Following this, a period of fluid maintenance and a gradual return to a normal diet is advocated. The rationale for this approach is to provide bowel rest and to prevent the possibility of food-induced malabsorption (360) . Intravenous therapy is needed for severely sick children, who are (i) in shock and unable to drink fluids, (ii) persistently vomiting, and (iii) having stool losses of >100 ml/kg per h and (iv) who cannot tolerate oral fluids (360, 396) .
However, the routine use of intravenous hydration for less severely ill children has been questioned recently. Often oral sugar-electrolyte rehydration solutions are used in the United States for maintenance therapy of mild diarrhea with dehydration, as an interim feeding prior to grading to a normal diet, or are incorporated with early refeeding to restore nutritional losses (218, 360, 396 2, 1989 Introduction Adenoviruses are 70-to 75-nm, nonenveloped, icosahedral, ds deoxyribonucleic acid (DNA) viruses classified in the family Adenoviridae. Adenoviruses infect most species of mammals, birds, and amphibians (386) . Human and other mammalian adenoviruses are in the genus Mastadenovirus. There are 41 known distinct serotypes of human adenoviruses, now considered to be 41 species (386). The first adenovirus was originally isolated from adenoid tissue, and adenoviruses have been associated primarily with respiratory disease, as well as with ocular and genitourinary tract infections. Early reports also associated adenoviruses with diarrhea in infants and children, but actual causation was not determined (177, 257) . These adenoviruses associated with diarrhea could be isolated in routine cell cultures and consisted of lower serotypes.
During the last 13 years, adenoviruses have been detected in stools of patients with gastroenteritis (33, 108, 110, 119, 197, 232, 297, 300, 324) , using the technique of EM (Fig. 1B) , but often, they could not be isolated in routine cell cultures. These viruses that are not readily cultivable are called enteric or fastidious adenoviruses and represent new types, 40 and 41 (77). Some investigators have suggested using the term "fastidious" adenovirus for those adenoviruses that are detected by EM, in EIAs specific for types 40 and 41, or in special cell cultures such as 293 cells, but which cannot be propagated in commonly used routine cell culture (228) . The general term "enteric" adenovirus is often used for any adenovirus observed in stool by EM, in which cell culture propagation is not attempted. This terminology will be followed in this review.
Most of the research on the molecular biology of adenoviruses has been carried out on adenovirus serotypes 1 to 39. However, much of the basic molecular biology of these serotypes applies to the fastidious types 40 and 41 as well. Adenoviruses, including the fastidious ones, are 70-to 75-nm icosahedral viruses made up of 252 capsomeres. The outer capsid is composed of two main capsomere types. The first type is the 240-nonvertex hexon capsomeres and the second type is the 12-penton base capsomeres which form the 12 vertices of the icosahedran. A fiber vertex projection protrudes from the base of each penton (387) . The dsDNA core contains the linear dsDNA with a molecular weight of 20 x 106 to 25 x 106 (387) .
The capsid components have antigenic determinants with a wide range of specificities. The hexons are responsible for group, subgroup, and type specificities (387) . Mammalian adenoviruses share a common group-specific determinant that can be measured by the CF test. The antigens that specify the adenovirus serotypes are located on the hexon and are measured in the neutralization test. The penton capsomeres carry group and subgroup specificities. This group specificity is also shared by mammalian (human, simian, and canine) adenoviruses. The fibers carry subgroup and type specificities. This type specificity is measured by the HAI test (387) .
There are 41 different adenovirus serotypes (77) considered to be species by Wadell (386 The adenoviruses were first classified into groups or subgroups in several ways (168, 308, 387) . Huebner (168) divided the human adenoviruses into subgroups based on their oncogenicity for newborn hamsters. Subgroups A and B contained "highly" and "weakly" oncogenic adenoviruses, respectively. Nononcogenic adenoviruses that transformed rodent cells in vitro were classified into two subgroups, C and D (244) . Interestingly, this classification correlates with the subdivision of adenoviruses based on the G+C content of their genomes (130, 290) .
Since the above grouping of adenoviruses is based on properties representing <6% of the genome, Wadell et al. (386, 387) , studied the adenovirus relationships based on their virion polypeptides. These polypeptides are encoded by a major portion of the adenovirus genome. Based on their polypeptide pattern, adenovirus types 1 to 39 fell into subgroups A to D, with the exception of type 4, whose pattern did not fit and thus was classified into subgroup E. A fastidious adenovirus isolated from diarrheal stools studied by Wadell also had its own distinctive characteristic polypeptide pattern and was therefore placed in subgroup F (type 40).
Green et al. (131) (177, 257 Spratt et al. (341) found adenovirus by EM in 17% (7 of 41) of infants with diarrhea versus 5% (4 of 74) of asymptomatic controls. CPE was detected in six of eight inoculated HEp-2 cultures, and the viruses isolated were types 2 to 7.
In the late 1970s, several groups reported that some adenoviruses in diarrheal stools of pediatric patients that were detected by EM could not be cultivated. Flewett et al. (110) first reported a nosocomial outbreak of gastroenteritis in 32% (6 of 19) of patients in a long-stay children's ward of an orthopedic hospital in England. Adenovirus was detected in four of six sick children, but in none of the asymptomatic controls. Attempts to culture the virus in a number of cell culture types failed except that subtle CPE was seen in some HEp-2 cultures 10 to 20 days after inoculation. These effects were not seen on passage. In 3 of 30 patients in Johannesburg, South Africa, Schoub et al. (324) detected, by EM, adenoviruses that were fastidious. Although they produced CPE with typical nuclear inclusion bodies in human embryonic fibroblast cultures, they could not be passaged or typed.
By EM, Middleton et al. (253) , in Toronto, Ontario, Canada, found adenoviruses in 12.7% (85 of 669) of viruspositive stools from pediatric patients with gastroenteritis. The authors did not claim that all of these adenoviruses were true causative agents of disease since no control population was studied. However, adenoviruses were seen more frequently by EM than could be isolated in cell culture. The authors also noted that adenoviruses were sometimes accompanied by what appeared to be adenovirus satellite viruses.
Madeley et al. (232) , in Glasgow, Scotland, detected adenovirus in 11.5% (21 of 183) of babies under 2 years of age with diarrhea; 9 adenoviruses were detected only by cell culture, 10 were detected only by EM, and 2 were detected by both methods. Those detected only by EM showed some evidence of growth in rhesus monkey kidney, human amnion, and/or human embryonic kidney (HEK) cells by CPE, but they could not be passed or typed; EM of the cell cultures did not suggest viral replication. It appeared to these investigators that the chance of growing adenovirus was inversely related to the amount of virus seen by EM. This observation regarding fecal adenoviruses has been made by others. Bryden et al. (39) found that many fecal samples containing adenoviruses that could not be isolated in cell culture contained large numbers of particles, up to 1011 virions per ml.
In a four year study in Washington, D.C., Brandt et al. (33) , detected significantly more uncultivatable adenoviruses in pediatric inpatients with gastroenteritis (5.1%, or 31 of 604, only 5 of which grew in cell culture) than from inpatient controls (1.9% or 10 of 522, 6 of which grew in cell culture). Similar results were seen in outpatients with gastroenteritis. This strongly suggested that these noncultivable viruses played a role in acute enteric disease.
Similarly, Richmond et al. (300) From the above studies, it can be seen that fastidious adenoviruses have been found in many parts of the world. They are probably the second most important cause of infantile gastroenteritis after rotavirus. Adenoviruses were found to be the second most common enteric virus detected by EM in a number of studies from the United States, United Kingdom, Scandinavia, and South Africa (30, 32, 33, 110, 185, 198, 324, 367) . It was the third most common virus in other studies from the United States (284, 302) , Canada (253), India (235) , and South Africa (89) and the fourth most common virus in a Scottish study (232) , although none were detected in one South African study (322) .
In many instances, fastidious adenovirus infections may occur throughout the year with no seasonal variation, according to reports from the United States, Canada, and Scotland (30, 31, 195, 253, 302) , although there is a tendency toward more cases in the warmer months in reports from the United States (33, 185) , United Kingdom (108) , Scandinavia (381) , Japan (51) , and South Africa (89, 198, 324) . Fastidious adenovirus infection tends to be endemic, rather than epidemic, although outbreaks in hospital nurseries have oc-VOL. 2, 1989 on October 26, 2017 by guest http://cmr.asm.org/ Downloaded from 70 CHRISTENSEN curred. Fastidious adenoviruses usually infect and cause symptoms in children up to the age of 3 years, but primarily in those 2 years or younger (110, 195, 381) .
Clinical Features
The symptoms associated with fastidious adenovirus infection have been studied by a number of investigators. Diarrhea appears to be the predominant symptom, with (195, 300, 370) or without (110) vomiting. The severity has ranged from mild, afebrile illness (110) to a fatal or "comatose state" (395) due primarily to dehydration. Reports of the duration of symptoms have been 2 to 4 days (110), a mean of 5 days (324), a mean of 7 days (300), and 4 to 8 days (195) . In a Swedish study (370) , diarrhea lasted 4 to 23 days with a mean of 9 days for those infected with type 40 and 2 to 47 days with a mean of 12 days for those with type 41 infection, with one-third of the type 41 patients having symptoms for 14 days or longer. Adenovirus-infected patients have milder disease with less pronounced vomiting and less fever and diarrhea than rotavirus-infected patients (367) .
Respiratory symptoms have also been associated with gastroenteritis in which adenoviruses have been detected in the patients' stools. In one study (381) , clinical signs of respiratory tract infection was present in 31% of patients with diarrhea in which adenovirus was detected in their stools. In this study, adenovirus was detected by a RIA test in which the antisera used were prepared against a type 2 hexon antigen, so that the group antigen was detected. In still another study (409) , the stools of 14 of 27 patients with diarrhea were found to contain the common hexon antigen of adenovirus, using an EIA test. Of these 14 patients, 13 also had respiratory symptoms such as cough, wheezing, or rhinorrhea; 6 of these had X-ray evidence of pneumonia; and 3 had bilateral conjunctivitis. Thus, it was concluded that the enteric types not only cause acute gastrointestinal disease, but also can be associated with a high rate of respiratory disease.
The role of fastidious adenoviruses (types 40 and 41) in causing respiratory symptoms and that of respiratory adenoviruses (lower-numbered types) in causing diarrhea have been of great interest, but also a problem for the interpretation of data. In some of the earlier studies, adenoviruses were detected in stools by EM or by EIA or RIA tests with antisera to an adenovirus group antigen. Thus, one cannot determine in which outbreaks or with what incidence fastidious adenoviruses were found and what disease was attributable to lower-numbered, nonfastidious types. In addition, the term enteric refers only to adenoviruses detected in stools, without indicating their fastidiousness or type. Thus, it has been recommended that the term fastidious refer only to those adenoviruses that cannot be propagated in routine cell culture or are typed as 40 or 41 or both (228) .
With techniques becoming available to differentiate between the fastidious and nonfastidious adenoviruses in stools, the role of both groups in causing respiratory and gastrointestinal symptoms could be more thoroughly evaluated. In one study by Uhnoo (370) , 21% of the patients with adenovirus types 40 and 41 also had respiratory symptoms, i.e., tonsillitis, pharyngitis, otitis, coryza, or cough. Patients who had diarrhea due to "established" adenovirus types, i.e., types 1 to 39, had diarrhea of shorter duration and higher fevers, and 79% had respiratory symptoms.
Similarly, Leite et al. (215) detected adenovirus in stools of 39 of 746 children with gastroenteritis by IEM or EIA or both. Of these 39, 25 could be propagated in HEp-2 cells and neutralized by one of the antisera to types 1 to 18 . The remaining 14 of the 39 could be propagated only in special 293 cells and were not neutralized by antisera to types 1 to 31. Thus, they concluded that "respiratory" adenoviruses could probably be responsible for gastroenteritis. Since fastidious adenoviruses have been associated with respiratory symptoms in some reports, the evaluation of the presence of adenoviruses in stools is a difficult diagnostic dilemma (215) . However, in another study, Uhnoo et al. (367) found respiratory symptoms to occur only rarely in patients infected with types 40 and 41 and concluded that these adenoviruses were restricted to the intestinal tract.
Other problems with interpretation of adenoviruses observed in diarrheal stools include (i) long-term shedding of adenoviruses in the stool and (ii) simultaneous infection with different enteric and respiratory tract adenoviruses. For example, Fox et al. (117) found that adenoviruses 1, 2, and 5 could be excreted from the intestinal tract without symptoms for at least 2 years after a primary infection. Other investigators have also found that types 1 and 2 especially may be shed in the stools for many months (195) .
Kidd et al. (195) , in a 2-year study, obtained stool samples containing adenoviruses from 71 children, and serial samples were obtained from 35 of these children. Adenoviruses were detected by EM and by routine cell culture. However, there was no certainty that an adenovirus seen by EM was the one that grew in routine cell culture. The longest interval in which the same serotype (type 2) was isolated was 231 days. The investigators found that adenoviruses of different established serotypes may be shed by one child in succession or simultaneously over a period of days. Four children shed two adenovirus types and three children shed three adenovirus types over a period of 1 to 5 months. In two of these cases, two types were isolated from the same stool. Thus, dual and triple infections are probably common in children, with prolonged and overlapping infection by different serotypes. Of the 71 children, at least 36 shed fastidious adenovirus, and 9 of these children shed fastidious adenovirus and known lower serotypes at different times. Although common established serotypes were shed over several weeks or more, excretion of the fastidious adenoviruses was not seen for longer than 8 days, at least in the amount needed to be observed by EM.
Brandt et al. (29) addressed the problem of simultaneous infections with different enteric and respiratory tract viruses. Infants and young children in whom adenovirus or rotavirus was visualized in their stools were tested for the simultaneous presence of respiratory viral pathogens in their respiratory tracts. Nearly 11% had dual respiratory and enteric viral infections. Non-adenovirus respiratory tract pathogens were seen in 8.5% (4 of 47) of gastroenteritis inpatients, 50% (8 of 16) of respiratory inpatients, and 19% (12 of 63) of total inpatients with visualized fecal adenovirus. Respiratory syncytial virus was the most common respiratory tract pathogen isolated from these dually infected patients, followed by parainfluenza virus type 3.
To summarize, in cases of gastroenteritis, it is probably important to use a diagnostic test that specifically detects types 40 and 41 per se. Since a type 40-and 41-specific EIA is now commercially available (Adenoclone-Type 40/41; Cambridge BioScience, Worcester, Mass.), this test could be used in conjunction with one of the commercially available rotavirus tests on stool specimens from cases of gastroenteritis. Initially adenoviruses were detected in stools by routine cell culture (nonfastidious types) and by direct EM (both fastidious and nonfastidious types). In earlier studies, adenoviruses in stool extracts could also be detected by counterimmunoelectrophoresis (288) and immunoelectroosmophoresis (174) . RIAs and ETAs to detect adenovirus in stools have also been described. Halonen et al. (141) Several of the detection tests described above were developed because fastidious adenovirus types 40 and 41 from stools could not be propagated in routine cell cultures in the laboratory. However, Takiff et al. (353) found that these fastidious adenoviruses could be propagated in Graham's 293 cells (128) , HEK cells that were transformed by exposing the cells to sheared fragments of adenovirus type 5 DNA (128) .
In routine cell types, such as HeLa cells, the in vitro replication of fastidious adenoviruses is probably blocked at a very early stage in the viral growth cycle, whereas this block does not occur in the 293 cells (353) . In 293 cells inoculated with stools containing fastidious adenovirus, small foci of progressive adenovirus-like CPE appear after several days (353) . The specificity of the CPE can be determined by direct fluorescent-antibody test (353) . However, the pattern of granular nuclear and cytoplasmic fluorescence differs from the fluorescent pattern seen with lower-numbered adenoviruses (353) . Fastidious adenoviruses grow better when they are seeded into 293 cells that are subconfluent (36). Graham's 293 cells have also been used in suspension culture for isolating fastidious adenoviruses (329) .
One problem with the use of 293 cells is that lowernumbered non-fastidious adenoviruses also grow well in them (35, 36) . In one study by Brown et al. (35) , 4 of 15 stools positive for type 40 adenovirus also contained a lower-numbered adenovirus type, and these lower-numbered types overgrew the type 40 strain.
In addition to the 293 cells, Kidd and Madeley (197) reported that 42% of fastidious adenoviruses from stools could be propagated in Chang's human conjunctival cell line, with development of typical adenoviral CPE. However, not all fastidious adenoviruses could be propagated in this cell type.
Immunology
Although extensive immunologic studies have been carried out on lower-numbered adenoviruses, there have been only a few reports on the immunity to adenoviruses 40 and 41 per se. Kidd et al. (193) obtained 377 serum samples from children under the age of 12 years living in the United Kingdom, New Zealand, Hong Kong, Guatemala, Gambia, and Kuwait. By a neutralization test, they found that at least 33% of the sera from the United Kingdom, Hong Kong, and the isolated country of Gambia had neutralizing antibody to 40 and 41. Sixty percent of the New Zealand sera was positive. The Kuwaiti sera had a lower percentage (15%) of positive sera, while all of the Guatemalan sera were negative.
In a study of the age distribution of antibody in Japan, Shinozaki et al. (328) found that 20% of 1 to 6 month olds and (374) . Fastidious adenovirus infection is not as common or as serious as rotavirus infection, and therefore the need for an adenovirus vaccine is not as pressing as that for a rotavirus vaccine. Treatment includes maintaining proper electrolyte balance and fluid levels, as in rotavirus infection.
NORWALK AND NORWALK-LIKE VIRUSES

Introduction
Whereas rotavirus primarily causes disease in infants and young children, Norwalk and Norwalk-like viruses primarily infect and cause disease in older children and adults. The Norwalk virus is a small, round virus, 25 to 30 nm in diameter, which was first detected by Kapikian et al. (187) by EM examination of stools of patients from an outbreak of winter vomiting disease occurring in Norwalk, Ohio, in 1968. Several other viruses resemble Norwalk virus by their morphology, the type of clinical illness they cause, and their low concentration in infected stools. However, some are antigenically similar and others are antigenically distinct from the Norwalk agent. These other agents, discovered in the 1970s, include the Hawaii agent (401), the Montgomery County agent (356) , discovered in Maryland, and the Snow Mountain (SM) agent, discovered in Colorado (87) . These viruses, including the Norwalk agent, cannot be cultivated in vitro, so that little is known of their biophysical and biochemical characteristics. The viruses can be propagated only in human volunteers and in chimpanzees (133) .
Since very small amounts of these viruses are excreted in the stools of infected persons, the viruses can be detected by IEM, using convalescent sera from recovering patients.
Frequently, they may not be detected at all. In such cases, a diagnosis may be made by detecting a significant serologic rise in antibody titer.
Other small, round viruses which were originally thought to be Norwalk-like viruses are now considered to be candidate parvoviruses and include the Cockle agent and the Ditchling agent (6, 42) .
Physical Characteristics
Norwalk and Norwalk-like agents observed by EM or IEM are 27 to 30 nm in diameter and have been described as picorna/parvovirus-like, as well as resembling caliciviruses (described below). However, their fine morphology is difficult to distinguish because of their small size and because, by IEM, the virions are coated with antibody. Since these agents cannot be cultivated in vitro, biophysical and biochemical studies have been carried out on virus purified from diarrheal stools of infected patients.
The Norwalk agent is resistant to ether, since it lacks a lipid-containing outer envelope (22, 84) . The Norwalk agent is relatively resistant to acid (pH 2.7 at room temperature), and this characteristic may protect the agent in its passage through the stomach (22, 84) . The Norwalk agent is also relatively heat stable; after a viral suspension is heated to 60'C for 30 min, the suspension can still produce disease in some volunteers (22, 84) .
Norwalk virions, purified by Greenberg et al., appear to contain a single primary structural protein with a molecular weight of 59,000 (133) . In addition, this group detected a soluble viral protein with a molecular weight of 30, 000 in the stools of Norwalk-infected patients. The protein structure of the virion is similar to that of the Caliciviridae, which has one major structural protein of 60,000 to 71,000 molecular weight (133, 233) . Parvoviruses differ in that they have three different structural proteins (133 The epidemiologic and clinical characteristics of the non-Norwalk outbreaks suggest that they were caused by agents resembling, but antigenically distinct from, the Norwalk agent. They were similar in their incubation period, the prevalence of symptoms, and the duration of illness. In two of these outbreaks, 27-nm particles resembling Norwalk virus were seen in the stools of affected patients.
Although the role of Norwalk virus and antigenically related viruses in large and small outbreaks of gastroenteritis is well documented, little is known about their endemic role in disease causation. This is due in part because patients usually are not hospitalized, and routine diagnostic laboratories do not have the reagents available for detecting these viruses or viral antibodies.
Since Norwalk and similar viruses tend to infect older children and adults in developed nations, one would expect that these older populations would have a higher prevalence of antibodies than in small children. This is in contrast to rotavirus, in which antibody development occurs early in life, due to early infection with this virus. Several studies have addressed the issue of the development of antibody to Norwalk virus throughout different age groups which would reflect the acquisition of Norwalk infection. Blacklow et al. (21) found that acquisition of antibody to Norwalk virus in American subjects was minimal during childhood and was in the range of only 5% before the age of 12 years. Throughout adolescence and early adulthood, the prevalence of antibody rose rapidly, reaching 45% in 18 to (189) . The vomiting may be caused by a decrease in gastric mobility, which may be more pronounced in children than in adults (189) .
Although the disease seldom requires hospitalization, serious illness has occurred in rare instances. Hospitalization of a total of three middle-aged persons for severe dehydration was reported in two outbreaks (189) . In one nursing home outbreak, three patients needed intravenous fluids, but they were not hospitalized. In another nursing home outbreak, two elderly debilitated patients died after the onset of gastroenteritis, but supposedly the deaths were due to diffuse atherosclerosis (189) .
Pathogenesis. The amount of virus needed to initiate an infection in human volunteers has been estimated. In one study, the Norwalk agent had a titer of at least 500 human disease-producing doses in the first human passage filtrate, whereas the disease was produced with only undiluted stool filtrate from a second human passage (22) . In a study with the SM agent, Dolin et al. (87) reported that five of six volunteers given 1.0 to 0. Agus et al. (2) also showed that, in addition, jejunal brush border enzyme activities, including alkaline phosphatase, sucrase, and trehalase levels, were decreased. Convalescence enzyme levels determined 2 weeks later returned to the base-line rates in all volunteers. These reduced enzyme levels may contribute to the pathogenesis of Norwalk disease. However, in contrast to the intestinal lesions seen with invasive bacterial agents, such as Shigella spp. and enteropathogenic Escherichia coli, in Norwalk-induced disease the mucosa remained intact. Rectal biopsies taken at the height of illness showed a normal histologic pattern. There was an absence of fecal leukocytes in Norwalk-induced illness. Thus, the colonic mucosa is relatively spared in this syndrome as compared with bacterial gastroenteritis. Inoculated volunteers who were asymptomatic had normal jejunal biopsies. Schreiber et al. (325) described the pathologic lesions seen in volunteers who ingested stool filtrates containing the Hawaii agent. The volunteers developed intestinal mucosal lesions in the proximal small intestine that were similar to those lesions seen in Norwalk infection. However, these two agents are immunologically distinct. Lesions from symptomatic volunteers showed shortening of the villi and an increased cellularity of the lamina propria. Many villous absorptive cells were decreased in height, and some had vacuolated cytoplasm. Increased numbers of mononuclear cells and some polymorphonuclear leukocytes infiltrated the intercellular spaces between epithelial cells. Many polymorphonuclear leukocytes and increased numbers of mononuclear cells were seen throughout the lamina propria. Two of four volunteers without symptoms developed mucosal lesions indistinguishable from those of sick volunteers 48 h after ingestion of virus. The remaining two of four asymptomatic volunteers had normal mucosal epithelia (325). Dolin et al. (86) also described jejunal biopsies from Hawaii agent-infected volunteers and found that they were similar, but not identical, to those seen in Norwalk virus infection. Light microscopy of biopsy specimens showed an intact mucosa, moderately blunted villi, and a moderate inflammatory cell infiltrate in the lamina propria, consisting of both polymorphonuclear and mononuclear cells. EM showed distorted and markedly shortened microvilli on intact epithelial cells, enlarged pale mitochondria containing indistinct membranes, and moderate widening of intercellular spaces filled with an amorphous electron-dense material. The biopsies of the asymptomatic volunteers remained normal. By 2 to 3 weeks postinfection, the lesions had disappeared.
Laboratory Diagnosis
The laboratory diagnosis of Norwalk and similar agents has been hindered by the inability to propagate these viruses in vitro. Reagents are available in research laboratories, but are not available for routine diagnostic laboratories. In addition, routine laboratory diagnosis of these agents is not carried out since patients do not usually require hospitalization, where testing is usually done.
Cell and organ culture. Attempts at propagating the Norwalk agent in a number of types of cell cultures has failed. However, its replication has been attempted in organ cultures of human fetal intestine (22, 84 In both assays, patient convalescent serum was used as a capture antibody and acute-phase serum was used as a control antibody to coat microtiter plate wells. To use the RIA to detect viral antigen, suspect stool suspensions were added to both acute-and convalescent-phase serum-coated wells. This was followed by the addition of detector antibody consisting of IgG purified from convalescent-phase serum that was labeled with 1251.
To detect the presence of antibody in patient sera, Greenberg et al. (138) used a blocking RIA. In this test a stool suspension known to contain Norwalk virus was added to the capture-antibody-coated wells. The patient sera to be tested for Norwalk antibody were then added. Lastly, a 125I-labeled detector antibody was added. A similar RIA for Norwalk virus has been described by Blacklow et al. (21) . Dolin et al. (88) have described a similar RIA for the SM agent. These RIAs were shown to be highly specific and sensitive. However, other problems have been associated with them. The primary problem has been the rapid loss of reactivity of the 125I-labeled detector antibody, which is good for <1 week after labeling. In addition, there are the usual costs, hazards, and disposal problems associated with the use of radioactive substances.
Because of the inherent problems with the RIA, an EIA for Norwalk antigen detection has been developed (149, 150) . This test is similar to the RIAs. Again, the reagents were human clinical materials and differed only in that the Treatment includes maintaining electrolyte and fluid levels in patients.
CALICIVIRUSES
Caliciviruses were known to infect mammals before they were discovered in humans. They were first described in humans by Madeley and Cosgrove (231) and Flewett and Davies (112) , who found them by EM in the stools from babies with diarrhea.
Caliciviruses were originally considered to be in the family Picornaviridae but have now been placed in the new family Caliciviridae. They are RNA viruses about 30 nm in diameter. Caliciviruses derive their name from the 32 cup-shaped depressions on the surface of their virions. This gives their periphery a spiky appearance and causes the formation of a Star of David configuration at certain rotations of the virion (Fig. 1C) . The Star of David configuration is formed by six peripheral hollows surrounding a seventh central hollow (227, 331) . The buoyant density of human calicivirus in CsCl ranges from 1.38 to 1.40 glcm3, with a peak at 1.39 g/cm3 (346) .
Caliciviruses primarily cause gastroenteritis in infants and young children. They can cause gastroenteritis in the general pediatric population (67, 267, 346) as well as outbreaks in institutions including schools (248) , orphanages (53, 54) , a mother-baby psychiatric unit (69) , and nosocomially in pediatric wards in hospitals (67, 341) . Sporadic cases have occurred in the United Kingdom, Norway, Australia, Canada, United States, India, and Bulgaria (68) .
Most individuals are infected with caliciviruses at a very young age. In Madeley and Cosgrove's first report, all but two children were 2 months old or younger. In other reports, patients were 2 to 20 and 1 to 27 months old in orphanage outbreaks (53, 54) ; 1 to 18 months old in a mother-baby psychiatric unit (69); 6 weeks to 13 years, with a peak at 1 to 6 months old in a general hospitalized population (67) ; and 4 to 6 years old in a school outbreak (248) . However, in one outbreak occurring in a residential home for the elderly, 18 affected residents were 77 to 102 years old, and the 32 affected staff members were 16 to 68 years old (70) .
Calicivirus infections were found to occur throughout the year, with peaks in the winter months, according to one 30-month study (67) . Sporadic as well as more epidemic infection can occur (67) .
The symptoms of calicivirus infection are about as severe as those seen with rotavirus infection and may be indistinguishable from them (67) . In two studies, diarrhea was reported as the predominant feature (341, 346) . In one study, infants had either diarrhea only or diarrhea plus vomiting (53) . In one 30-month study of hospitalized pediatric patients (67) , diarrhea was the most common symptom in 89%, 50% had vomiting in addition to diarrhea (usually in the 4 to 6 year olds), one-third had upper respiratory tract symptoms, and about 20% had fever. One patient had projectile vomiting (67) . In 4 to 6 year olds in a school, most patients had nausea and vomiting, although some also had diarrhea (248) . In initially well babies in the mother-baby psychiatric ward, some had mild vomiting and diarrhea lasting only 1 day, some had severe vomiting and diarrhea lasting 7 to 9 days, and one had very severe projectile vomiting (69) . Two orphanage outbreaks lasted 4 to 6 days, and viral shedding was correlated with the days of illness, which rarely occurred for more than 10 days (54). In the 30-month study (67) , the illness lasted an average of 4 days, with a range of 2 to 11 days. In the initial report of Flewett and Davies (112), calicivirus was found in the small bowel obtained at the necropsy of a 22-month-old child who died of gastroenteritis, but the investigators were not sure of its significance. Caliciviruses have also been found in the stools of well individuals (53, 231) , and in the outbreak in babies in the mother-baby psychiatric unit, none of the mothers or staff developed symptoms (69) . However, in the elderly in the residential home (70) , 100% of the sick residents and staff had diarrhea and 50% of both groups had vomiting. A few of the staff members also reported headaches, general aches, and malaise, although the elderly residents did not.
In the 30-month study of patients hospitalized with gastroenteritis in the United Kingdom, 6.6% was due to calicivirus (67) , while in another 3-year study in Japan, 1.2% was due to calicivirus (346) . Thus, caliciviruses are responsible for only a minority of viral gastroenteritis among hospitalized patients, although they have worldwide prevalence (see below).
In several studies there was good correlation between enteric disease and the presence of caliciviruses in stool seen by direct EM (53, 54, 69, 70) . In addition, paired acute and convalescent serum samples were obtained from the patients, and rises in antibody titers to caliciviruses were seen by 1EM (53, 69, 70, 265) . Caliciviruses in patient stools were used as the source of virus for IEM.
No one has been able to isolate the human caliciviruses in routine cell cultures (53, 70, 346) , although other mammalian caliciviruses such as feline calicivirus can readily be propogated in cells of their species (231) . In addition to EM for the detection of caliciviruses in stools, a solid-phase RIA has been developed by Nakata et al. (264) . They prepared guinea pig hyperimmune serum for the test by using as an antigen calicivirus particles purified from patient stools. They found the RIA to be much more sensitive than direct EM for detecting caliciviruses in stools. With a blocking RIA, their test was shown to be specific for calicivirus. This RIA is also advantageous in that caliciviruses are smaller and present in lower numbers in stools than rotaviruses and thus are harder to detect by EM. In another report, Nakata et al. (266) described a similar EIA that was as sensitive as their RIA.
To determine the prevalence of antibody to calicivirus in the general population in Japan, Sakuma et al. (312) used IEM to detect antibody in 83 serum specimens. The agerelated prevalence of antibody was 23% in 0 to 5 month olds, 30% in 6 to 23 months olds, 65% in 2 to 5 year olds, and 90% in school children and adults. Similar results were found by Nakata et al. (266) in sera from healthy children in the United States. All (100%) infants 0 to 3 months old had calicivirus antibody, whereas the percentage dropped to 25% for 4 to 11 month olds; by the ages of 4 to 6 years, however, 100% of children had developed antibody. Thus, calicivirus appears to infect the population early in life.
Nakata et al. (263) used their blocking RIA to determine antibody prevalence in 390 At least two strains of calicivirus have been recovered from children. However, the agent responsible for the outbreak in the home for the elderly was antigenically distinct from the two strains isolated from children (70) .
To date, vaccines cannot be developed to control calicivirus infection, since the virus cannot be propagated in vitro. Treatment consists primarily of maintaining the proper electrolyte balance and fluid balance, as in rotavirus gastroenteritis. This is important since calicivirus infection is probably as serious as rotavirus gastroenteritis.
ASTROVIRUSES
Human astroviruses were first discovered by EM in the stools of infants with diarrhea by Madeley and Cosgrove (229, 230) . Shortly thereafter, astroviruses were found to infect various species of mammals, including cattle, sheep, and pigs (209, 400) , causing diarrhea, especially in the young of these species.
Astroviruses have been isolated in the United Kingdom (7, 210, 229, 230) Norway (199) , Federal Republic of Germany (226) , Japan (204) , and North America. They are responsible for about 5% of infantile gastroenteritis, including nosocomial infections. The Marin County agent, discovered in elderly patients with diarrhea in a convalescent hospital in California, is also an astrovirus (148, 278) . Their appearance has been described in detail by Madeley (227) . They are 28-to 30-nm, round virus particles with a smooth edge, as opposed to caliciviruses which have a rough edge. Most of the virus particles have a star-shaped configuration on their surface (Fig. 1D ). This star configuration can have either five or six points, whereas caliciviruses have only six-pointed stars. The point of the astrovirus star radiates our from a central point or knob and has no hollow center as does the calicivirus. The astrovirus buoyant density in cesium chloride has been reported to be 1.39 to 1.40 (204) and 1.33 to 1.34 (226) g/cm3.
There appear to be at least five distinct serotypes of human astroviruses (199, 209, 214) . These have been distinguished by an immunofluorescence test and by immunosorbent EM. In the former test, acetone-fixed astrovirus-infected LLC-MK2 or HEK cells were used. In the latter test, astrovirus antisera against the various strains were raised in rabbits and used to coat Formvar-coated EM grids. The astrovirus suspensions were added to these grids. The grids were examined and the number of virus particles was counted. The only cross-reaction seen was with serotypes 1 and 3. There were no cross-reactions of any of the five human strains with bovine or ovine astroviruses. From strains collected over a 10-year period in the United Kingdom, serotype 1 appears to be the most prevalent, accounting for 77% of the astroviruses. The remaining types 2 to 5 had a similar incidence, ranging from 5 to 7%.
In determining the incidence of astrovirus infection in Japan, Konno et al. (204) found that 50% of young adults tested by IEM had antibodies to astroviruses. They also found astrovirus antibodies in the commercial gamma globulin preparation they tested. By IEM, they found no crossreaction with caliciviruses, Norwalk virus, polioviruses, or a coxsackievirus B.
Children, from infancy to 5 to 7 years of age, are most likely to develop symptomatic disease with astroviruses (7, 204, 210) , although exposed adults can also develop mild disease, but with less frequency (204, 210, 278) . In one study (210) , older children were also found to be less likely to develop disease than younger children. Asymptomatic infection can also occur among infants and young children (7, 229) .
The incubation period appears to be 24 to 36 hours, similar to those for other gastroenteritis viruses (204) . Symptoms can last from 12 h to 3 to 4 days (7, 204, 210) .
In one study, all symptomatic children had watery diarrhea, while only one-third had vomiting (210) . However, in another study, some children had vomiting only, while the remainder suffered from both vomiting and diarrhea (7) . In a third study, the rates of symptoms were as follows: vomiting, 74%; diarrhea, 30%; abdominal pain, 49%; and fever, 30% (204) . Clinical illness appeared to be less severe than with rotavirus (210) .
Astroviruses can be detected in stool suspensions by direct EM (7, 210, 229, 230) . Konno et al. (204) found that the star configuration was much more distinct if the particles were stained with phosphotungstic acid rather than with uranyl acetate.
Astroviruses, including the Marin County agent (278), can be isolated and propagated in HEK cells to which trypsincontaining medium is added (148, 213, 214) . Astrovirusinfected HEK cells can be used for immunofluorescence tests and EIAs for serologic studies (148, 209, 214) .
Antibodies can be detected by IEM. Antibody rises can be observed in paired acute and convalescent sera obtained from patients (204, 210) . In addition, astrovirus-specific IgM can be detected by IEM after fractionation of patient sera by sucrose density gradient centrifugation (7) .
There is no specific treatment for astrovirus infection, similar to other viral gastroenteritides. Nonspecific treatment consists of maintaining fluids and electrolyte balance, although astrovirus infection appears to be less severe than rotavirus infection (210) .
CORONAVIRUSES
Coronaviruses are enveloped, medium-sized, positivestranded RNA viruses that were first discovered in patients with upper respiratory tract illness. These viruses have also been associated with diarrheal diseases in mammals, especially newborns. They may be involved in human gastrointestinal disease (296) , since by direct EM coronavirus-like particles (CVLP) have been seen in stools of patients with acute nonbacterial gastroenteritis and necrotizing enterocolitis.
Coronaviruses are approximately 80 to 150 nm in diameter. They are seen as rounded or pleomorphic particles that have club-shaped projections on their surface, called peplomers (296) . These projections on the rounded particles give the appearance of the corona of the sun, hence, the virions' name. 78 CHRISTENSEN Mortensen et al. (260) found that CVLP in stools in infants with diarrhea were morphologically distinct from respiratory coronaviruses in that the fecal CVLP had a flexible-appearing fringe whereas the respiratory coronaviruses had a more rigid-appearing fringe. The CVLP in stools also had more closely spaced peplomers.
Two respiratory coronaviruses, OC43 and 229E, are responsible for common colds and have been well characterized. CVLP from stools have not been well characterized, since most investigators have not been able to cultivate them. However, Gerna et al. (11, 122, 123) purified CVLP directly from the stools of two patients with gastroenteritis, using sucrose density gradient ultracentrifugation. This group also used the purified particles to study biophysical characteristics. The two strains of purified human enteric coronavirus (HEC) of Gerna et al., HECV-24 and HECV-35, had a buoyant density of 1.20 g/cm3, a value in agreement with those reported for human and animal coronaviruses.
In several epidemiologic studies, CVLP have been observed in the stools of normal individuals as well as in diarrheal or necrotizing enterocolitis stools (334) , so that the role of CVLP in gastrointestinal disease has been questioned. However, in some studies, a positive correlation has been made between the incidence of fecal CVLP and gastrointestinal illness. In a prospective study, Gerna et al. (122, 123) found that, by EM, 16% of 208 gastroenteritis patients had CVLP in their stools compared with only 2% of 182 controls. Similarly, Mortensen et al. (248) found that 39% (49 of 126) of diarrheal stools were positive for CVLP by EM. In addition to the correlation or lack of correlation of CVLP with disease, some controversy or questions have arisen over the nature of the CVLPs. This is due in part to the inability of many investigators to propagate CVLP in vitro. In addition, in some instances the CVLP seen may not have been true virus particles, but rather, artifactual (283, 298, 322) . In some instances, the CVLP may be normal intestinal epithelial cell components, consisting of R-bodies (rodcontaining bodies) and C-bodies (coccoid or glycocalyceal bodies), which resemble CVLP (283) . The possibility has also been considered that these CVLP may be mycoplasmas. However, efforts to propagate them on mycoplasma media have failed (260) .
Viruses from human diarrheal stools have also been observed (by EM) that resemble coronaviruses, but are morphologically more similar to the newly described toroviruses (122) . The human toro-like viruses are antigenically similar to the Breda virus. The toroviruses include Breda virus isolated from calves with diarrhea and Berne virus, which was isolated from a horse. The toroviruses are morphologically similar to coronaviruses in that they are medium-sized viruses with a peplomer-bearing envelope. However, their polypeptides are of different molecular weights than those of coronaviruses, and they appear to be negative-stranded RNA viruses, whereas the coronaviruses are positive stranded. Thus, in humans, some CVLP seen by EM may actually be members of the torovirus group (122) . In summary, some investigators believe that the CVLP are a heterogeneous group of particles, some of which are true coronaviruses.
Enteric coronavirus infections, or infections by CVLP, tend to occur in the cooler, drier months of the years. In southern Arizona, where a large percentage of gastroenteritis appears to be caused by coronavirus, most of the cases occur in the fall and early winter (260) . Most cases of gastroenteritis, as well as necrotizing enterocolitis, occur in infants. Mortensen et al. (260) found that 49 patients with CVLP-associated gastroenteritis ranged in age from 1 month to 12 years. Of these 49 patients, 88%o were <2 years old and 71% were <1 year old. The median duration of the illness was 7 days. Diarrhea occurred in 94%; vomiting, in 51%; fever, in 63%; and occult blood, in the stools of 18%. Eighteen percent had at least one other identifiable enteric pathogen, including Salmonella, Shigella, and Campylobacter spp. and one enterovirus. Mortensen et al. (260) suggested that nursing might have a protective effect on preventing illness due to coronavirus-like agents, since weaned infants seemed to be at risk for severe CVLP-associated disease.
Serologic studies have been carried out for various purposes: (i) for epidemiologic purposes, (ii) to study the immune response to enteric coronavirus infection, and (iii) to study possible cross-reactivity of fecal coronaviruses with known respiratory coronaviruses.
In a retrospective study, Gerna et al. (122, 123) found that 27% of sera from 62 patients with gastroenteritis reacted with coronavirus OC43 by neutralization and HAI tests, whereas only 2% of control sera reacted. They also immunized guinea pigs and mice with the CVLP purified from the stools of two gastroenteritis patients by sucrose density gradient ultracentrifugation. In an IEM test, they used the animal sera to the two patients' strains, animal sera to OC43, and one patient's convalescent serum. In this test, they found a two-way cross between OC43, and their two human enteric coronavirus strains. Thus, their fecal isolates appeared to share a common antigen(s) with respiratory coronaviruses. However, Mortensen et al. (260) 
